Reactions Weekly

, Volume 1697, Issue 1, pp 22–22 | Cite as

Afatinib/erlotinib/osimertinib

Various toxicities and developement of drug resistance to afatinib and osimertinib: case report
Case report
  • 9 Downloads

Reference

  1. Svaton M, et al. Patient with three EGFR mutations - gradual development of resistance to previous targeted treatment. [Czech]. Klinicka Onkologie 31: 53-58, No. 1, Jan 2018. Available from: URL: http://doi.org/10.14735/amko201853 - Czech RepublicCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations